• MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance Stocktwits Thu, 09 Jul 2026 13:12:31 GMT
• Enterprise value to EBITDA forward of Moleculin Biotech, Inc. – NASDAQ:MBRX TradingView Thu, 09 Jul 2026 07:12:52 GMT
• price to earnings forward of moleculin biotech, inc. – lse:0k2h TradingView Wed, 08 Jul 2026 00:03:30 GMT
• Moleculin Biotech focuses on oncology pipeline and Nasdaq listing AD HOC NEWS Tue, 07 Jul 2026 14:03:56 GMT
• moleculin ceo, walter klemp, highlights positive preliminary miracle trial results in virtual investor 'what this means' segment marketscreener.com Tue, 07 Jul 2026 13:11:22 GMT
• Moleculin CEO discusses preliminary results from leukemia trial Investing.com Mon, 06 Jul 2026 13:00:23 GMT
• moleculin ceo, walter klemp, highlights positive preliminary miracle trial results in virtual investor 'what this means' segment The Manila Times Mon, 06 Jul 2026 12:50:14 GMT
• moleculin biotech ceo discusses preliminary miracle trial results for annamycin in virtual investor segment Quiver Quantitative Mon, 06 Jul 2026 12:44:00 GMT
• Moleculin says early MIRACLE trial data support Annamycin in leukemia Stock Titan Mon, 06 Jul 2026 12:33:00 GMT
• MBRX stock drops 25% as Moleculin Biotech's interim cancer trial data falls short of significance MSN Mon, 06 Jul 2026 11:09:22 GMT
• mbrx stock drops 25% as moleculin biotech's interim cancer trial data falls short of significance Stocktwits Sun, 05 Jul 2026 22:46:35 GMT
• mbrx stock drops 25% as moleculin biotech's interim cancer trial data falls short of significance MSN Fri, 03 Jul 2026 01:39:58 GMT
• mbrx stock drops 25% as moleculin biotech's interim cancer trial data falls short of significance Stocktwits Thu, 02 Jul 2026 16:41:23 GMT
• maxim group maintains moleculin biotech(mbrx.us) with buy rating, maintains target price $10 Moomoo Thu, 02 Jul 2026 12:31:00 GMT
• what do moonlake's latest week 40 hs results really mean for investors Kavout | AI Wed, 01 Jul 2026 19:15:53 GMT
• MBRX stock drops 25% as Moleculin Biotech's interim cancer trial data falls short of significance MSN Wed, 01 Jul 2026 17:58:07 GMT
• MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance TradingView Tue, 30 Jun 2026 18:52:03 GMT
• Moleculin Biotech (MBRX) Reports Positive Efficacy Results in Ph GuruFocus Tue, 30 Jun 2026 15:23:09 GMT
• moleculin biotech, inc. (moleculin) recently announced the interim analysis results of its phase 2/3 "miracle" clinical trial, sho... Bitget Tue, 30 Jun 2026 14:38:24 GMT
• moleculin biotech announces unblinded efficacy results from miracle trial part a TipRanks Tue, 30 Jun 2026 14:24:36 GMT
• moleculin biotech reports promising annamycin aml trial data TipRanks Tue, 30 Jun 2026 13:05:46 GMT
• Moleculin Biotech, Inc. Shares June 2026 Investor Presentation and Key Regulatory Updates Minichart Tue, 30 Jun 2026 13:02:00 GMT
• Moleculin Biotech (NASDAQ: MBRX) raises $2.7M as 1.36M warrants are exercised Stock Titan Tue, 30 Jun 2026 12:30:21 GMT
• moleculin’s leukemia drug tops control in interim trial readout Stock Titan Tue, 30 Jun 2026 12:30:00 GMT
• H.C. Wainwright Maintains Moleculin Biotech(MBRX.US) With Buy Rating, Maintains Target Price $22 Moomoo Tue, 30 Jun 2026 07:00:00 GMT
• Moleculin reports positive interim data from AML trial Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Form 4 Moleculin Biotech Inc For: 24 June By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 08:28:35 GMT
• moleculin biotech (mbrx) ceo reports rsu vesting, tax-share withholding and retained stake Stock Titan Thu, 25 Jun 2026 01:16:52 GMT
• Moleculin Biotech (MBRX) CFO exercises RSUs, uses shares to cover taxes Stock Titan Thu, 25 Jun 2026 01:16:51 GMT
• Moleculin Biotech (MBRX) CSO exercises RSUs with tax withholding, increases common stock stake Stock Titan Thu, 25 Jun 2026 01:16:51 GMT
• Moleculin Biotech (MBRX) CEO reports RSU vesting, tax-share withholding and retained stake Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• moleculin biotech | 4: statement of changes in beneficial ownership of securities-officer picker donald h Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• sprb stock drops after company pushes back application submission timeline for experimental sanfilippo syndrome therapy Stocktwits Tue, 23 Jun 2026 16:14:53 GMT
• Trending Stocks Today | Moleculin Biotech Shoots up 106.41% Pre-Market Moomoo Tue, 23 Jun 2026 08:05:00 GMT
• moleculin biotech inc (mbrx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• moleculin biotech inc (mbrx) dividends & stock splits: historical payouts and event timeline TradingKey Fri, 19 Jun 2026 06:30:16 GMT
• moleculin biotech inc (mbrx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Fri, 19 Jun 2026 03:28:17 GMT
• moleculin biotech inc (mbrx) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 03:00:20 GMT
• moleculin biotech inc (mbrx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:44:00 GMT
• moleculin biotech inc (mbrx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 03:11:47 GMT
• moleculin biotech inc (mbrx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 23:22:10 GMT
• moleculin biotech inc (mbrx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 23:21:15 GMT
• moleculin biotech inc (mbrx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 19:26:12 GMT
• mbrx q1 2026 earnings: significant eps miss as clinical-stage biotech reports wider-than-expected loss - surprise factor analysis dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT
• moleculin biotech inc (mbrx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• moleculin biotech inc (mbrx) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• moleculin biotech (mbrx) sees modest uptick as stock consolidates near support - covered call etf dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• moleculin biotech inc. (mbrx) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 13 Jun 2026 00:21:00 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding MSN Mon, 08 Jun 2026 11:16:49 GMT
• moleculin biotech announces positive market assessment for annamycin in relapsed/refractory aml (r/r aml) – key clinical advantage... Minichart Fri, 05 Jun 2026 13:57:00 GMT
• moleculin biotech enrolls 45 subjects in clinical trial geneonline.com Fri, 05 Jun 2026 07:42:26 GMT
• Leukemia drug Annamycin wins doctor and insurer support in new survey Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Strong physician interest in Annamycin reported by Moleculin (NASDAQ: MBRX) Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Moleculin market study shows strong physician, payer interest in Annamycin for R/R AML TradingView Fri, 05 Jun 2026 07:00:00 GMT
• Independent Market Research Finds Strong Physician Intent GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• moleculin highlights strong market interest in annamycin aml therapy TipRanks Fri, 05 Jun 2026 07:00:00 GMT
• moleculin biotech reports strong physician interest in annamycin for r/r aml treatment, highlighting unmet needs and positive mark... Quiver Quantitative Fri, 05 Jun 2026 07:00:00 GMT
• moleculin ceo, walter klemp, highlights 45 subject enrollment milestone in recent virtual investor what this means segment marketscreener.com Fri, 05 Jun 2026 07:00:00 GMT
• a new hope for aml: annamycin's promise meets biotech's precarious reality BriefGlance Fri, 05 Jun 2026 07:00:00 GMT
• moleculin biotech (mbrx) holds steady at $2.46 – key levels in focus - overvalued signals newsline.com Thu, 04 Jun 2026 13:36:41 GMT
• leukemia trial of annamycin hits 45-patient milestone, mid‑2026 data ahead Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding MSN Mon, 01 Jun 2026 02:45:19 GMT
• moleculin biotech (mbrx) holds near key support as modest uptick signals cautious trading - trend following picks The Legal Advocate Fri, 29 May 2026 16:40:15 GMT
• moleculin presents asco data showing no detectable cardiotoxicity with annamycin at high exposure TradingView Fri, 29 May 2026 13:33:01 GMT
• Cancer trial tests Annamycin beyond chemo limits, finds no heart toxicity Stock Titan Fri, 29 May 2026 07:00:00 GMT
• moleculin biotech stock (us60855l2034): nasdaq-listed micro-cap biotech trades near multi-month lows Ad-hoc-news.de Fri, 29 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) edges higher on modest volume: support holds near $2.65 - resistance breakout stocks newsline.com Fri, 29 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) shares asco data on annamycin cardiac safety and miracle trial Stock Titan Fri, 29 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) holds steady at $2.73 amid consolidation phase - high reward trades newsline.com Thu, 28 May 2026 07:00:00 GMT
• Moleculin Biotech (MBRX) Rises 3.27%: Breaking Above Support with Resistance in Sight - Earnings Miss Risk dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• moleculin biotech’s miracle trial data exceeds historical benchmarks for aml treatment geneonline.com Tue, 26 May 2026 22:09:37 GMT
• moleculin biotech, inc. files sec form 8-k and releases may 2026 investor presentation Minichart Tue, 26 May 2026 12:20:00 GMT
• Moleculin Biotech (NASDAQ: MBRX) posts new May 2026 investor presentation Stock Titan Tue, 26 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) holds steady at $2.39 as trading remains flat - vold alert newsline.com Mon, 25 May 2026 07:00:00 GMT
• moleculin biotech shares slide after announcing 1-for-25 reverse split MSN Sun, 24 May 2026 09:00:31 GMT
• moleculin biotech inc. (mbrx) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 23 May 2026 00:27:00 GMT
• moleculin presents cardiac safety data for annamycin at asco by investing.com Investing.com South Africa Fri, 22 May 2026 09:41:13 GMT
• annamycin cardiac safety data at asco 2026 for moleculin (nasdaq: mbrx) Stock Titan Fri, 22 May 2026 07:00:00 GMT
• moleculin highlights abstract accepted for poster presentation at the 2026 asco annual meeting highlighting cardiac safety data fo... The Manila Times Fri, 22 May 2026 07:00:00 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding MSN Thu, 21 May 2026 13:40:44 GMT
• Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data fo... Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• Moleculin presents cardiac safety data for Annamycin at ASCO Investing.com Thu, 21 May 2026 07:00:00 GMT
• moleculin's annamycin aims to solve chemo's heart problem BriefGlance Thu, 21 May 2026 07:00:00 GMT
• moleculin's annamycin shows no heart toxicity in trials, advancing aml cancer treatment. Pluang Thu, 21 May 2026 07:00:00 GMT
• pooled trials of cancer drug annamycin find no cardiotoxicity signal Stock Titan Thu, 21 May 2026 07:00:00 GMT
• moleculin biotech, inc. presents cardiac safety data for annamycin at 2026 asco annual meeting Quiver Quantitative Thu, 21 May 2026 07:00:00 GMT
• mbrx stock price, quote & chart | moleculin biotech inc (nasdaq:mbrx) ChartMill Wed, 20 May 2026 07:00:00 GMT
• moleculin biotech stock (us60855l2034): maxim group keeps buy rating AD HOC NEWS Tue, 19 May 2026 21:56:39 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding MSN Tue, 19 May 2026 04:19:50 GMT
• moleculin biotech stock (us60855l2034): clinical progress keeps biotech investors watching AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• moleculin biotech: runway to support planned operations into 3q 2026 >mbrx Moomoo Sat, 16 May 2026 13:45:42 GMT
• what does gf score 27/100 say about moleculin biotech (mbrx) aft GuruFocus Sat, 16 May 2026 04:26:05 GMT
• moleculin biotech: runway to support planned operations into 3q 2026 >mbrx Moomoo Fri, 15 May 2026 21:18:49 GMT
• mbrx: pivotal aml trial hits key enrollment, 40% remission rate; q1 net loss $12.8m, cash runway into q3 TradingView Fri, 15 May 2026 12:34:56 GMT
• maxim group maintains moleculin biotech(mbrx.us) with buy rating, maintains target price $10 Moomoo Fri, 15 May 2026 12:31:00 GMT
• buy rating reiterated on moleculin biotech as miracle trial progress and safety profile support unchanged $22 price target TipRanks Fri, 15 May 2026 11:13:26 GMT
• h.c. wainwright maintains moleculin biotech(mbrx.us) with buy rating, maintains target price $22 富途牛牛 Fri, 15 May 2026 10:35:00 GMT
• What Does GF Score 27/100 Say About Moleculin Biotech (MBRX) Aft GuruFocus Fri, 15 May 2026 07:00:00 GMT
• Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Moleculin Biotech | 8-K: Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Tr... Moomoo Fri, 15 May 2026 07:00:00 GMT
• leukemia trial shows 40% remissions; first miracle data unblinding due june 2026 Stock Titan Fri, 15 May 2026 07:00:00 GMT
• moleculin (nasdaq: mbrx) q1 2026 loss deepens while miracle aml trial progresses Stock Titan Fri, 15 May 2026 07:00:00 GMT
• moleculin biotech, inc. (nasdaq: mbrx) reports q1 2026 financial results and clinical trial updates Minichart Fri, 15 May 2026 07:00:00 GMT
• moleculin biotech reports promising early results in miracle trial for aml treatment with 40% composite complete remission rate Quiver Quantitative Fri, 15 May 2026 07:00:00 GMT
• mbrx stock price, quote & chart | moleculin biotech inc (nasdaq:mbrx) ChartMill Fri, 15 May 2026 07:00:00 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding MSN Fri, 15 May 2026 05:29:24 GMT
• buy rating reiterated on moleculin biotech as miracle trial progress supports unchanged $10 price target TipRanks Thu, 14 May 2026 22:11:02 GMT
• Moleculin Biotech Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Thu, 14 May 2026 07:00:00 GMT
• MBRX: Annamycin advanced in pivotal AML trial; net loss widened, and more funding is needed for operations TradingView Thu, 14 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) q4 2025 earnings: $13.04 eps surges past $-6.24 estimates - forward eps estimate newsline.com Thu, 14 May 2026 07:00:00 GMT
• moleculin biotech (mbrx) widens q1 loss and flags funding gap for miracle trial Stock Titan Thu, 14 May 2026 07:00:00 GMT
• maxim group maintains moleculin biotech(mbrx.us) with buy rating, maintains target price $10 Moomoo Thu, 14 May 2026 07:00:00 GMT
• moleculin biotech, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 14 May 2026 07:00:00 GMT
• moleculin biotech expects first unblinding of miracle trial data by june 30 TipRanks Wed, 13 May 2026 16:34:28 GMT
• moleculin approaching first miracle trial unblinding; preliminary cr ~30% vs 17–18% soc TradingView Wed, 13 May 2026 12:03:00 GMT
• Moleculin Biotech (MBRX) Approaches Key Data Release in AML Tria GuruFocus Wed, 13 May 2026 07:00:00 GMT
• Leukemia study nears June data reveal after early 30% remission rate Stock Titan Wed, 13 May 2026 07:00:00 GMT
• Moleculin Announces Imminent MIRACLE Trial Unblinding as GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• Moleculin reports preliminary data from AML trial ahead of unblinding Investing.com Wed, 13 May 2026 07:00:00 GMT
• nano-cap moleculin biotech approaches key leukemia trial data unblinding Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
Moleculin Biotech, Inc(NASDAQ:MBRX) 
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates for the treatment of highly resistant tumors and viruses in the United States. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or r...
Website: http://www.moleculin.com
Founded: 2015
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology